These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21934688)

  • 1. Effects of annual vs triennial mammography interval on breast cancer incidence and mortality in ages 40-49 in Finland.
    Parvinen I; Chiu S; Pylkkänen L; Klemi P; Immonen-Räihä P; Kauhava L; Malila N; Hakama M
    Br J Cancer; 2011 Oct; 105(9):1388-91. PubMed ID: 21934688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Service screening mammography reduces breast cancer mortality among elderly women in Turku.
    Parvinen I; Helenius H; Pylkkänen L; Anttila A; Immonen-Räihä P; Kauhava L; Räsänen O; Klemi PJ
    J Med Screen; 2006; 13(1):34-40. PubMed ID: 16569304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976-2009.
    Parvinen I; Heinävaara S; Anttila A; Helenius H; Klemi P; Pylkkänen L
    Br J Cancer; 2015 Mar; 112(5):918-24. PubMed ID: 25688742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial.
    Moss SM; Wale C; Smith R; Evans A; Cuckle H; Duffy SW
    Lancet Oncol; 2015 Sep; 16(9):1123-1132. PubMed ID: 26206144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
    Miller AB; Wall C; Baines CJ; Sun P; To T; Narod SA
    BMJ; 2014 Feb; 348():g366. PubMed ID: 24519768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of screening for breast cancer in women under 50 years at entry: the Kotka pilot project in Finland.
    Hakama M; Pukkala E; Kallio M; Godenhjelm K; Svinhufvud U
    Int J Cancer; 1995 Sep; 63(1):55-7. PubMed ID: 7558452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland.
    Anttila A; Koskela J; Hakama M
    J Med Screen; 2002; 9(4):153-8. PubMed ID: 12518004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
    Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
    Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer incidence and mortality patterns in women with breast symptoms in the mammography screening programme: A matched cohort analysis.
    Singh D; Malila N; Pitkäniemi J; Anttila A
    Int J Cancer; 2019 Jun; 144(12):2928-2935. PubMed ID: 30511466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.
    Bakker MF; de Lange SV; Pijnappel RM; Mann RM; Peeters PHM; Monninkhof EM; Emaus MJ; Loo CE; Bisschops RHC; Lobbes MBI; de Jong MDF; Duvivier KM; Veltman J; Karssemeijer N; de Koning HJ; van Diest PJ; Mali WPTM; van den Bosch MAAJ; Veldhuis WB; van Gils CH;
    N Engl J Med; 2019 Nov; 381(22):2091-2102. PubMed ID: 31774954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program.
    Hofvind S; Ursin G; Tretli S; Sebuødegård S; Møller B
    Cancer; 2013 Sep; 119(17):3106-12. PubMed ID: 23720226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year annual incidence and clinico-molecular features of breast cancer after the last negative screening mammography at age 68-69.
    Bucchi L; Ravaioli A; Baldacchini F; Giuliani O; Mancini S; Vattiato R; Rossi PG; Campari C; Canuti D; Di Felice E; de Bianchi PS; Ferretti S; Bertozzi N; Falcini F;
    Eur Radiol; 2022 Feb; 32(2):834-841. PubMed ID: 34363132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.